Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
361 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Currently Recruiting (1)
  • Closed (2)

Medical Condition

  • Show all (118)
  • Autoimmune Disorders (5)
  • Blood Disorders (39)
    • Amyloidosis (14)
    • (-) Anemia (1)
    • Sickle Cell Disease (5)
  • (-) Cancer (2)
    • Leukemia (1)
  • Developmental Disorders (1)
  • Endocrine & Metabolic Disease (1)
  • Hair and Skin Disorders (1)
  • Healthy Volunteers (5)
  • Heart Disease (1)
  • Kidney Disease (1)
  • Lung Disease (3)
  • Neurological Disorders (49)
  • Obstetrics & Gynecology (1)
  • Pediatrics (3)
  • Psychiatric Disorders (6)
Displaying 1 - 3 of 3

Tissue Repository For The Collection of Hematologic Samples

Condition: Cancer
Investigator: Suzanne Lentzsch, MD
Status: Currently Recruiting
Subjects are being asked to volunteer to allow excess specimen (blood, bone marrow samples, samples of pleural and pericardial effusions, ascites, tissue, and bone samples) removed from patients with and who are undergoing procedures for hematological and non-hematological disorders for storage…
Read More

A study for patients with Iron Refractory Iron-Deficiency Anemia (IRIDA) using study drug Triferic

Condition: Blood Disorders / Anemia
Investigator: Katherine Ender, MD
Status: Closed
The main purpose of the study is to find out whether Triferic, when taken by mouth (orally) with Shohls solution, is safe and effective for the treatment of Iron Refractory Iron-Deficiency Anemia (IRIDA). The study drug, ferric pyrophosphate citrate (FPC), is also called Triferic. It is an iron salt that has been approved by the Food and Drug Administration…
Read More

Study of Vedolizumab in Subjects Undergoing Stem Cell Transplantation

Condition: Cancer / Leukemia
Investigator: Ran Reshef, MD
Status: Closed
The main purpose of this research study is to investigate if a drug called Vedolizumab is safe and effective in preventing acute graft-versus-host disease (attack of donor cells on recipient healthy organs after transplant) of the gut in comparison to placebo (dummy drug). This will be studied in patients undergoing Allogeneic Hematopoietic Stem Cell…
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Contact RecruitMe Terms of Use Privacy Policy ©2025 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science